The existing authors conducted an open-label pilot research that administered psilocybin to 15 cure-resistant tobacco/nicotine-dependent people who smoke, in the context of cognitive behavioral therapy for cigarette smoking cessation [58]. Individuals ended up administered ~0.29 mg/kg oral psilocybin over the participant’s focus on day to Stop us